Lean Mass Hyperresponder

The correct answer with regard to the risk association is in this very unique context, is we really don't know. Well, i think it's a great first step, but this is definitly a topic we need to ihead on. We're already in the process of doing that with the clinical trial that we actually have, lean mass hyper responder. And so enrolment for that trial is still going on at this time here, in november, december 20 21.